Cargando…

Electronic cigarettes as a smoking cessation aid for patients with cancer: beliefs and behaviours of clinicians in the UK

OBJECTIVES: To explore UK clinicians’ beliefs and behaviours around recommending e-cigarettes as a smoking cessation aid for patients with cancer. DESIGN: Cross-sectional online survey. SETTING: England, Wales, Scotland and Northern Ireland. PARTICIPANTS: Clinicians involved in the care of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Brett, Jo, Davies, Emma L, Matley, Fiona, Aveyard, Paul, Wells, Mary, Foxcroft, David, Nicholson, Brian, De Silva Minor, Shiroma, Sinclair, Lesley, Jakes, Sarah, Watson, Eila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678366/
https://www.ncbi.nlm.nih.gov/pubmed/33444179
http://dx.doi.org/10.1136/bmjopen-2020-037637
Descripción
Sumario:OBJECTIVES: To explore UK clinicians’ beliefs and behaviours around recommending e-cigarettes as a smoking cessation aid for patients with cancer. DESIGN: Cross-sectional online survey. SETTING: England, Wales, Scotland and Northern Ireland. PARTICIPANTS: Clinicians involved in the care of patients with cancer. PRIMARY AND SECONDARY OUTCOMES: Behavioural Change Wheel capability, opportunity and motivation to perform a behaviour, knowledge, beliefs, current practice around e-cigarettes and other smoking cessation practices. METHOD: Clinicians (n=506) completed an online survey to assess beliefs and behaviours around e-cigarettes and other smoking cessation practices for patients with cancer. Behavioural factors associated with recommending e-cigarettes in practice were assessed. RESULTS: 29% of clinicians would not recommend e-cigarettes to patients with cancer who continue to smoke. Factors associated with recommendation include smoking cessation knowledge (OR 1.56, 95% CI 1.01 to 2.44) and e-cigarette knowledge (OR 1.64, 95% CI 1.06 to 2.55), engagement with patients regarding smoking cessation (OR 2.12, 95% CI 1.12 to 4.03), belief in the effectiveness of e-cigarettes (OR 2.36 95% CI 1.61 to 3.47) and belief in sufficient evidence on e-cigarettes (OR 2.08 95% CI 1.10 to 4.00) and how comfortable they felt discussing e-cigarettes with patients (OR 1.57 95% CI 1.04 to 2.36). CONCLUSION: Many clinicians providing cancer care to patients who smoke do not recommend e-cigarettes as a smoking cessation aid and were unaware of national guidance supporting recommendation of e-cigarettes as a smoking cessation aid.